Tel:
Hubei Vanz Pharm Co.,ltd
Hubei Vanz Pharm Co.,ltd

Warrantable quality,Trustable service!

Home ProductsActive Pharmaceutical Ingredient

Velpatasvir Pharmaceutical Raw Materials Active Pharmaceutical Ingredients

Velpatasvir Pharmaceutical Raw Materials Active Pharmaceutical Ingredients

  • Velpatasvir Pharmaceutical Raw Materials Active Pharmaceutical Ingredients
  • Velpatasvir Pharmaceutical Raw Materials Active Pharmaceutical Ingredients
Velpatasvir Pharmaceutical Raw Materials Active Pharmaceutical Ingredients
Product Details:
Place of Origin: china (mainland)
Brand Name: vanz
Certification: coa
Model Number: medicine grade
Payment & Shipping Terms:
Packaging Details: in aluminium or depand on client requirements
Delivery Time: 3days after paid
Payment Terms: T/T, Western Union, MoneyGram
Contact Now
Detailed Product Description
Molecular Weight: 883.01 Molecular Formular: C49H54N8O8
Quality Standard: Enterprise Standard CAS#: 1377049-84-7
Density: 1.3 Purity: 99%
High Light:

medicine raw material

,

raw pharmaceutical materials

Velpatasvir Pharmaceutical Raw Materials Active Pharmaceutical Ingredients

 

Product details:

 

Treat all six main HCV genotypes in the first scheme, velpatasvir, a new drug, and was the first to treat all six main type of HCV.
 

The FDA's drug evaluation and research center director of antimicrobial products in said: "the approval for a broad range of patients with chronic hepatitis c provides a treatment and treatment options."Priority review.

 

velpatasvir, an investigational pan-genotypic NS5A inhibitor, for the treatment of chronic genotype 1-6 hepatitis C virus (HCV) infection.

 

In phase 2 trials, treatment with the combination of the nucleotide polymerase inhibitor sofosbuvir and the NS5A inhibitor velpatasvir resulted in high rates of sustained virologic response in patients chronically infected with hepatitis C virus (HCV) genotype 2 or 3.

 

Sofosbuvir works by interfering with the activity of an enzyme (NS5B) used by HCV-infected cells. Velpatasvir works by interfering with another HCV enzyme called NS5A.

 

Results:

 

Overall, 99% of participants who took sofosbuvir + velpatasvir were cured of hepatitis C 12 weeks after the cessation of therapy. Such high cure rates occurred regardless of the genotype or subtype of HCV. This cure, referred to as a sustained virological response, is written as SVR12. None of the participants who received placebo were cured.

 

 

Specifications:

 

Product name Velpatasvir
CAS NO. 1377049-84-7
Synonyms Velpatasvir
Category Pharmaceutical Raw Materials,Active Pharmaceutical Ingredients,Bulk Drugs,Fine Chemicals.
Standard purity:>99%
Appearance Velpatasvir powder
Shelf life 2 years
Usage Velpatasvir is used for treat Hepatitis C virus.
Storage Velpatasvir should be stored in a well-closed container at low temperature, keep away from moisture, heat and light.

 

Chemical structure :

 

 

 

Velpatasvir Pharmaceutical Raw Materials Active Pharmaceutical Ingredients 0

 

 

Contact Details
Hubei Vanz Pharm Co.,ltd

Contact Person: Ms. Wendy Wang

Tel: +86 15927784577

Fax: 86-27-84492310

Send your inquiry directly to us
Hubei Vanz Pharm Co.,ltd
Room 2114, Jingkai future town, Longyang Road, Wuhan Economic & Technological Development District, Wuhan City, Hubei , China
Tel:86-27-84492310
Mobile Site Privacy PolicyChina pharmaceutical active ingredients Supplier. Copyright © 2016 - 2022 api-pharmaceuticals.com. All Rights Reserved. Developed by ECER